文献
J-GLOBAL ID:202002247880139390
整理番号:20A2457385
CRISPR/Cas13: COVID-19の潜在的治療選択肢【JST・京大機械翻訳】
CRISPR/Cas13: A potential therapeutic option of COVID-19
著者 (6件):
Lotfi Melika
(School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran)
,
Lotfi Melika
(Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran)
,
Lotfi Melika
(USERN Office, Zanjan University of Medical Sciences, Zanjan, Iran)
,
Rezaei Nima
(Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran)
,
Rezaei Nima
(Research Center for Immunodeficiencies, Children’s Medical Center, Tehran University of Medical Sciences, Tehran, Iran)
,
Rezaei Nima
(Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran)
資料名:
Biomedicine & Pharmacotherapy
(Biomedicine & Pharmacotherapy)
巻:
131
ページ:
Null
発行年:
2020年
JST資料番号:
A0845C
ISSN:
0753-3322
資料種別:
逐次刊行物 (A)
記事区分:
文献レビュー
発行国:
オランダ (NLD)
言語:
英語 (EN)